6-136792541-C-CCGCCG
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BS1BS2
The NM_001438058.1(MAP3K5):c.96+99_96+103dupCGGCG variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0032 ( 2 hom., cov: 0)
Exomes 𝑓: 0.000062 ( 0 hom. )
Consequence
MAP3K5
NM_001438058.1 intron
NM_001438058.1 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00
Publications
2 publications found
Genes affected
MAP3K5 (HGNC:6857): (mitogen-activated protein kinase kinase kinase 5) Mitogen-activated protein kinase (MAPK) signaling cascades include MAPK or extracellular signal-regulated kinase (ERK), MAPK kinase (MKK or MEK), and MAPK kinase kinase (MAPKKK or MEKK). MAPKK kinase/MEKK phosphorylates and activates its downstream protein kinase, MAPK kinase/MEK, which in turn activates MAPK. The kinases of these signaling cascades are highly conserved, and homologs exist in yeast, Drosophila, and mammalian cells. MAPKKK5 contains 1,374 amino acids with all 11 kinase subdomains. Northern blot analysis shows that MAPKKK5 transcript is abundantly expressed in human heart and pancreas. The MAPKKK5 protein phosphorylates and activates MKK4 (aliases SERK1, MAPKK4) in vitro, and activates c-Jun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK) during transient expression in COS and 293 cells; MAPKKK5 does not activate MAPK/ERK. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00322 (480/149090) while in subpopulation EAS AF = 0.0193 (95/4910). AF 95% confidence interval is 0.0162. There are 2 homozygotes in GnomAd4. There are 263 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 480 AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001438058.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MAP3K5 | NM_001438058.1 | c.96+99_96+103dupCGGCG | intron | N/A | NP_001424987.1 | ||||
| MAP3K5 | NM_005923.4 | MANE Select | c.-389_-385dupCGGCG | upstream_gene | N/A | NP_005914.1 | |||
| MAP3K5 | NM_001438579.1 | c.-831_-827dupCGGCG | upstream_gene | N/A | NP_001425508.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MAP3K5 | ENST00000698928.1 | c.96+103_96+104insCGGCG | intron | N/A | ENSP00000514039.1 | ||||
| MAP3K5 | ENST00000359015.5 | TSL:1 MANE Select | c.-385_-384insCGGCG | upstream_gene | N/A | ENSP00000351908.4 | |||
| MAP3K5 | ENST00000954598.1 | c.-385_-384insCGGCG | upstream_gene | N/A | ENSP00000624657.1 |
Frequencies
GnomAD3 genomes AF: 0.00320 AC: 477AN: 148980Hom.: 2 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
477
AN:
148980
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000619 AC: 1AN: 16164Hom.: 0 Cov.: 0 AF XY: 0.000126 AC XY: 1AN XY: 7930 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
16164
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
7930
show subpopulations
African (AFR)
AF:
AC:
0
AN:
266
American (AMR)
AF:
AC:
0
AN:
22
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
90
East Asian (EAS)
AF:
AC:
0
AN:
96
South Asian (SAS)
AF:
AC:
0
AN:
492
European-Finnish (FIN)
AF:
AC:
0
AN:
8
Middle Eastern (MID)
AF:
AC:
0
AN:
42
European-Non Finnish (NFE)
AF:
AC:
1
AN:
14610
Other (OTH)
AF:
AC:
0
AN:
538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00322 AC: 480AN: 149090Hom.: 2 Cov.: 0 AF XY: 0.00362 AC XY: 263AN XY: 72712 show subpopulations
GnomAD4 genome
AF:
AC:
480
AN:
149090
Hom.:
Cov.:
0
AF XY:
AC XY:
263
AN XY:
72712
show subpopulations
African (AFR)
AF:
AC:
61
AN:
40736
American (AMR)
AF:
AC:
57
AN:
15108
Ashkenazi Jewish (ASJ)
AF:
AC:
85
AN:
3446
East Asian (EAS)
AF:
AC:
95
AN:
4910
South Asian (SAS)
AF:
AC:
20
AN:
4778
European-Finnish (FIN)
AF:
AC:
16
AN:
9928
Middle Eastern (MID)
AF:
AC:
1
AN:
290
European-Non Finnish (NFE)
AF:
AC:
137
AN:
66932
Other (OTH)
AF:
AC:
8
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.